GGrantIndex
← Leaderboards

Robert Schwarcz

University Of Maryland Baltimore

Google Scholar ↗PubMed ↗ORCID ↗
$12,978,861
Attributed
$14,105,931
Total exposure
8
Grants
6
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $3.8M · FY2005–23
$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23

Funding mix

By agency

NIH$39,351,254 · 9

By mechanism

P50$33,490,324 · 5
R01$4,208,871 · 2
P01$1,229,934 · 1
R21$422,125 · 1

Top collaborators

Most similar at University Of Maryland Baltimore

Same institution · by research overlap

Others in their field

Top investigators on “Kynurenine”

Research focus

KynurenineKynurenic AcidAnimalsCognitiveSchizophreniaBrainPharmaceutical PreparationsBaseCognitive DeficitsRegulationPathologyN-Methyl-D-Aspartate ReceptorsAstrocytesFunctional DisorderAcuteTryptophanPlayDesignAdultPathway InteractionsImpaired CognitionInstitutionProgramsEtiology

Grant awards (55)

Kynurenic Acid and Cognitive Abnormalities in Schizophrenia$2,663,662
P50 · FY2023 · MH · contact PI
Targeted Manipulation of KYNA in Mice by Genetic and Pharmacological Means: Biochemical and Functional Effects$630,477
P50 · FY2023 · MH · contact PI
Administrative Core$284,087
P50 · FY2023 · MH · contact PI
Kynurenic Acid and Cognitive Abnormalities in Schizophrenia$2,859,662
P50 · FY2022 · MH · contact PI
Targeted Manipulation of KYNA in Mice by Genetic and Pharmacological Means: Biochemical and Functional Effects$467,615
P50 · FY2022 · MH · contact PI
Administrative Core$230,010
P50 · FY2022 · MH · contact PI
Kynurenic Acid and Cognitive Abnormalities in Schizophrenia$2,858,545
P50 · FY2021 · MH · contact PI
Targeted Manipulation of KYNA in Mice by Genetic and Pharmacological Means: Biochemical and Functional Effects$467,614
P50 · FY2021 · MH · contact PI
Administrative Core$230,011
P50 · FY2021 · MH · contact PI
Kynurenic Acid and Cognitive Abnormalities in Schizophrenia$2,845,732
P50 · FY2020 · MH · contact PI
Targeted Manipulation of KYNA in Mice by Genetic and Pharmacological Means: Biochemical and Functional Effects$467,615
P50 · FY2020 · MH · contact PI
Administrative Core$245,460
P50 · FY2020 · MH · contact PI
Kynurenic Acid and Cognitive Abnormalities in Schizophrenia$2,875,721
P50 · FY2019 · MH · contact PI
Targeted Manipulation of KYNA in Mice by Genetic and Pharmacological Means: Biochemical and Functional Effects$496,690
P50 · FY2019 · MH · contact PI
Administrative Core$384,510
P50 · FY2019 · MH · contact PI
Kynurenic Acid and Cognitive Abnormalities in Schizophrenia$2,304,248
P50 · FY2018 · MH · contact PI
Adminisstrative Core$474,077
P50 · FY2018 · MH · contact PI
Manipulation of Brain KYNA during Early Development: Short- and Long-term Effects$462,223
P50 · FY2018 · MH · contact PI
Kynurenic Acid and Cognitive Abnormalities in Schizophrenia$2,144,444
P50 · FY2017 · MH · contact PI
Adminisstrative Core$395,523
P50 · FY2017 · MH · contact PI
Manipulation of Brain KYNA during Early Development: Short- and Long-term Effects$391,069
P50 · FY2017 · MH · contact PI
Kynurenic Acid and Cognitive Abnormalities in Schizophrenia$159,977
P50 · FY2017 · MH · contact PI
Kynurenic Acid and Cognitive Abnormalities in Schizophrenia$2,144,444
P50 · FY2016 · MH · contact PI
Adminisstrative Core$439,638
P50 · FY2016 · MH · contact PI
Manipulation of Brain KYNA during Early Development: Short- and Long-term Effects$433,873
P50 · FY2016 · MH · contact PI
Kynurenic Acid and Cognitive Abnormalities in Schizophrenia$2,144,445
P50 · FY2015 · MH · contact PI
Adminisstrative Core$436,192
P50 · FY2015 · MH · contact PI
Manipulation of Brain KYNA during Early Development: Short- and Long-term Effects$434,482
P50 · FY2015 · MH · contact PI
Kynurenic Acid and Cognitive Abnormalities in Schizophrenia$99,999
P50 · FY2015 · MH · contact PI
Kynurenic Acid and Cognitive Abnormalities in Schizophrenia$2,144,444
P50 · FY2014 · MH · contact PI
Manipulation of Brain KYNA during Early Development: Short- and Long-term Effects$444,635
P50 · FY2014 · MH · contact PI
Adminisstrative Core$429,200
P50 · FY2014 · MH · contact PI
Endogenous Kynurenic Acid Modulates Prefrontal ACh Levels and Cognitive Behavior$364,957
R01 · FY2014 · MH
An NMDA Glycine Site Antagonist for the Treatment of Major Depressive Disorder$191,875
R21 · FY2014 · MH
Endogenous Kynurenic Acid Modulates Prefrontal ACh Levels and Cognitive Behavior$350,869
R01 · FY2013 · MH
An NMDA Glycine Site Antagonist for the Treatment of Major Depressive Disorder$230,250
R21 · FY2013 · MH
Endogenous Kynurenic Acid Modulates Prefrontal ACh Levels and Cognitive Behavior$365,989
R01 · FY2012 · MH
Endogenous Kynurenic Acid Modulates Prefrontal ACh Levels and Cognitive Behavior$366,462
R01 · FY2011 · MH
Endogenous Kynurenic Acid Modulates Prefrontal ACh Levels and Cognitive Behavior$383,739
R01 · FY2010 · MH
Kynurenic Acid Formation & Function during Development$214,982
P01 · FY2008 · HD · contact PI
Kynurenic Acid Formation & Function during Development$213,832
P01 · FY2007 · HD · contact PI
Kynurenines, Glia and Epilepsy$368,170
R01 · FY2006 · NS · contact PI
Kynurenic Acid Formation & Function during Development$213,822
P01 · FY2006 · HD · contact PI
Kynurenines, Glia and Epilepsy$367,212
R01 · FY2005 · NS
Kynurenic Acid Formation &Function during Development$207,596
P01 · FY2005 · HD
Kynurenines, Glia and Epilepsy$357,430
R01 · FY2004 · NS
Kynurenic Acid Formation &Function during Development$201,549
P01 · FY2004 · HD
Kynurenines, Glia and Epilepsy$332,434
R01 · FY2003 · NS
Kynurenines, Glia and Epilepsy$40,000
R01 · FY2003 · NS
KYNURENINES, GLIA AND EPILEPSY$312,896
R01 · FY2002 · NS
KYNURENIC ACID FORMATION AND FUNCTION DURING DEVELOPMENT$0
P01 · FY2002 · HD
KYNURENINES, GLIA AND EPILEPSY$303,782
R01 · FY2001 · NS
KYNURENIC ACID FORMATION AND FUNCTION DURING DEVELOPMENT$0
P01 · FY2001 · HD
KYNURENINES, GLIA AND EPILEPSY$294,931
R01 · FY2000 · NS
KYNURENIC ACID FORMATION AND FUNCTION DURING DEVELOPMENT$178,153
P01 · FY2000 · HD